2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Clazakizumab Acts on Endothelial Cells to Limit Antibody Mediated Damage

J. Lion¹, K. Poussin¹, E. Chong², D. Glotz³, N. A. Mooney¹
Clazakizumab as an Agent to Reduce Donor Specific HLA Antibodies and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation

S. C. Jordan¹, N. Ammerman¹, M. Toyoda², E. Huang¹, C. C. Nast³, A. Peng¹, S. Sethi¹, R. Najjar¹, I. Kim¹, K. Lim¹, J. Choi¹, A. Vo¹
Clinical and Pathologic Differences between Young and Old Living Donors in Young Kidney Transplant Recipients

C. Baek, H. Kim, H. Lee, Y. Kim, S. Park
Clinical Features and Prognosis of Diffuse Intrahepatic Biliary Stricture in Adult ABO-Incompatible Living Donor Liver Transplantation

J. Kwon, G. Song, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, H. Cho, I. Jeong, J. Choi, S. Yoo, S. Lee
Clinical Features of IgA Nephropathy Recurrence after Kidney Transplantation

H. HIGUCHI¹, K. Hotta², H. Harada¹, Y. Wada¹, A. Mitsuke¹, D. Iwami², N. Shinohara²
Clinical Impact of Race and Timing of Acute Rejection on Recipients of Kidney Transplant on Early Steroid Withdrawal Protocol

O. Adebiyi, S. Yaqub, W. Goggins, D. Mishler, T. Taber, A. Sharfuddin
Clinical Impact of Spontaenous Portosystemic Shunts on the Short Term Outcome of Liver Transplantation

E. A. Rodriguez¹, R. M. Perez², N. Zhang³, E. S. Lim³, C. R. Miller⁴, M. A. Schwartz², A. J. McGirr⁴, A. Srinivasan⁵, W. R. Hewitt⁵, A. C. Silva⁴, J. Rakela¹, H. E. Vargas¹
Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population

B. Valdepenas, J. Benken, E. Benedetti, Z. Hajjiri, A. Lichvar
Clinical Implications of Serum Mac-2 Binding Protein in Regular Follow Up after Pediatric Living Donor Liver Transplantation

T. Ueno¹, T. Kodama¹, Y. Noguchi¹, M. Nomura¹, R. Saka¹, Y. Takama¹, Y. Tazuke¹, K. Bessho², H. Okuyama¹
Clinical Importance of the Updated Oxford Classification in Allograft IgA Nephropathy

S. Park¹, H. Go², C. Baek², J. Jeong¹, Y. Kim¹, Y. Kim¹, Y. Kim², J. Lee³, S. Min¹, J. Ha¹, E. Song¹, Y. Kim¹, S. Park², K. Moon¹, H. Lee¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z